{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-028356","form_type":"8-K","ticker":"VIR","cik":"0001706431","company_name":"Vir Biotechnology, Inc.","filed_at":"2025-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.409269+00:00","generated_at":"2026-05-20T05:57:55.482846+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vir Biotechnology stockholders elect directors, approve executive pay, ratify auditor at 2025 annual meeting","bullets":["Jeffrey S. Hatfield and Saira Ramasastry elected as Class III directors each with >93 million votes for.","Advisory vote on executive compensation approved: 100.5 million for, 4.3 million against.","Ernst & Young LLP ratified as independent auditor for FY 2025 (116.3 million for).","All three proposals passed; no material change in governance or operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-028356","json":"https://secwatch.observer/filing/0001628280-25-028356.json","markdown":"https://secwatch.observer/filing/0001628280-25-028356.md","text":"https://secwatch.observer/filing/0001628280-25-028356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025028356/0001628280-25-028356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025028356/vir-20250529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T05:57:55.482846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}